Edition:
United States

Aap Implantate AG (AAQG.DE)

AAQG.DE on Xetra

1.21EUR
2 Dec 2016
Change (% chg)

€0.01 (+0.83%)
Prev Close
€1.20
Open
€1.20
Day's High
€1.21
Day's Low
€1.20
Volume
1,208
Avg. Vol
13,836
52-wk High
€1.75
52-wk Low
€1.00

AAQG.DE

Chart for AAQG.DE

About

aap Implantate AG is a Germany-based provider of medical devices for human muscular and skeletal systems. The Company focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in... (more)
No analyst recommendations are available for AAQG.DE.

Overall

Beta: 0.64
Market Cap(Mil.): €40.08
Shares Outstanding(Mil.): 30.83
Dividend: --
Yield (%): --

Financials

  AAQG.DE Industry Sector
P/E (TTM): -- 32.25 29.87
EPS (TTM): -0.36 -- --
ROI: -20.32 13.46 14.95
ROE: -21.97 17.16 16.29

BRIEF-aap Implantate Q3 EBITDA loss widens to 1.8 mln euros in continued operation

* Said on Monday Q3/2016 sales and EBITDA within the guidance; North America sales in 9 months of 2016 above expectations; important progress in LOQTEQ portfolio expansion

Nov 15 2016

BRIEF-Aap Implantate post Q2 EBITDA loss from continued oprations of 1.4 mln euros

* In the continued operation sales and EBITDA in Q2/2016 at 3.4 million euros ($3.80 million) (guidance: 2.5 million euros to 3.5 million euros) and -1.4 million euros (guidance: -2.5 million euros to -1.5 million euros) respectively

Aug 12 2016

BRIEF-Aap Implantate now sees FY EBITDA of 18.1 - 19.7 million euros

* Deconsolidation profit from the sale of Aap Biomaterials GmbH leads to an increase of 2016 EBITDA forecast for the group

Aug 10 2016

Earnings vs. Estimates